薬剤比較
Tirzepatide vs Alogliptin
Tirzepatide vs Alogliptin: Mounjaro dual GIP/GLP-1 vs Nesina DPP-4 for type 2 diabetes. Compare efficacy, weight loss, dosing and safety.
このページには比較できる項目がありません。
臨床的背景
Type 2 diabetes patients on oral DPP-4 inhibitors considering injectable dual-incretin therapy for greater glycemic control or weight loss.
結論
Tirzepatide generally outperforms Alogliptin on glucose and weight but is injectable with distinct risks, so choice depends on individual factors.
すべての薬剤比較